Announcements
- Result of AGM
- PDMR Dealing
- Total Voting Rights
- Participation in Upcoming Investor Conference
- MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference
- Signing of Strategic Platform License
- MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
- Holding(s) in Company
- Filing of Form 10-Q
- First Quarter Results
More ▼
Key statistics
As of last trade MaxCyte Inc (MYE0:DEU) traded at 4.44, -10.48% below its 52-week high of 4.96, set on Jun 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.56 |
---|---|
High | 4.58 |
Low | 4.26 |
Bid | 4.52 |
Offer | 4.70 |
Previous close | 4.30 |
Average volume | 28.50 |
---|---|
Shares outstanding | 104.54m |
Free float | 98.03m |
P/E (TTM) | -- |
Market cap | 522.72m USD |
EPS (TTM) | -0.3532 USD |
Data delayed at least 15 minutes, as of Jun 13 2024.
More ▼